CLOSE
MENU
For 2nd quarter FY8 2026 Financial Results Presentation
Apr 14, 2026
サブ-ナビゲーション
Company
CEO Message
Mission・2030 Vision
Leadership
Directors
Business Model
Brand Origin
Company Profile
Science/Pipleline
Focused Area
Pipeline Overview
CLK Inhibitor CTX-712
MALT1 Inhibitor CTX-177
CDK12 Inhibitor CTX-439
GCN2 Inhibitor CRD-1968099
News
Investor Relations
Management Policies
Top Message
Discloser Policy
Corporate Governance
Financial Information
Financial Highlights
Financial Indicators
Cash Flow
IR Library
Financial Results
Corporate Research Report
Stock Information
General Meeting of Shareholders
Stock Price
IR Calender
現在位置:
IR News
IR FAQ
Disclaimer
Career
Contact
Contact
Privacy Policy
Term of use
Sitemap
For 2nd quarter FY8 2026 Financial Results Presentation
Apr 14, 2026